Saturday, 19 September 2020

Drug Controller Approves Commercial Launch Of Low Cost Covid Test Feluda

The Drugs Controller General of India has approved the commercial launch of "Feluda", the Tata CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) COVID-19 test, the Council of...

from NDTV News - Topstories https://ift.tt/2FMnI1j
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

FIR Doesn't Say 'Honourable' Minister, Court Asks Top Official To Explain Why

The Allahabad High Court has sought an explanation from the additional chief secretary (home) of Uttar Pradesh over the non-mentioning of th...